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The Death Domain Kinase RIP Mediates
the TNF-Induced NF-kB Signal
The RIP death domain also binds RAIDD (RIP-associ-
ated ICH1/CED3-homologous protein with a death do-
main) (Duan and Dixit, 1997). Hence, RIP may directly
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link the TNFR1 complex to the ICE/caspase cascade.*Department of Genetics
RIP also interacts via separate domain(s) with TRAF2,Harvard Medical School
known to mediate the tumor necrosis factor receptor 2²Howard Hughes Medical Institute
(TNFR2)±NF-kB signal (Hsu et al., 1996b). Finally, RIP³Department of Pathology
interacts in vitro with the recently isolated death recep-Brigham and Women's Hospital
tor 3 (DR3 or WSL1 or Apo-3), a lymphoid-specific recep-Boston, Massachusetts 02115
tor also capable of inducing both apoptosis and NF-kB
activation (Chinnaiyan et al., 1996; Kitson et al., 1996;
Marsters et al., 1996).
The 74 kDa RIP protein consists of three domains:Summary
an N-terminal kinase domain, an a-helical intermediate
domain, and a C-terminal death domain (Stanger et al.,The death domain serine/threonine kinase RIP inter-
1995). RIP is unique among the known death domainacts with the death receptors Fas and tumor necrosis
proteins in that it contains an active serine/threoninereceptor 1 (TNFR1). In vitro, RIP stimulates apoptosis,
kinase domain capable of autophosphorylation (Hsu etSAPK/JNK, and NF-kB activation. To define the physi-
al., 1996b; Ting et al., 1996). Overexpression of the RIPologic role(s) that RIP plays in regulating apoptosis in
protein induces NF-kB activation (Hsu et al., 1996b; Tingvivo, we introduced a rip null mutation in mice through
et al., 1996), stress activated protein kinase/c-Jun Nhomologous recombination. RIP-deficient mice ap-
terminal kinase (SAPK/JNK) activation (Liu et al., 1996),pear normal at birth but fail to thrive, displaying exten-
and apoptosis (Stanger et al., 1995; Grimm et al., 1996;sive apoptosis in both the lymphoid and adipose tissue
Hsu et al., 1996b). In addition, dominant-negative formsand dying at 1±3 days of age. In contrast to a normal
of RIP and TRAF2have been shown tospecifically inhibitthymic anti-Fas response, rip2/2 cells are highly sensi-
tumor necrosis factor a (TNFa)±induced NF-kB activa-tive to TNFa-induced cell death. Sensitivity to TNFa-
tion and SAPK/JNK activation (Hsu et al., 1996b; Liu etmediated cell death in rip2/2 cells is accompanied by
al., 1996). Although the role of the SAPK/JNK pathway
a failure to activate the transcription factor NF-kB.
in apoptosis remains unclear, activation of the transcrip-
tion factor NF-kB has recently been associated with
protection from TNF-induced cell death (Beg and Balti-Introduction
more, 1996; Liu et al., 1996; Van Antwerp et al., 1996;
Wang et al., 1996). Thus, the TNFR1 complex is capableFas and tumor necrosis factor receptor 1 (TNFR1) are
of transducing signals that either activate or suppresscytokine receptors that activate cell death pathways
cell death. These disparate signals may be generatedthrough an intracellular homology region called the
through modulation of RIP.death domain (Nagata, 1997). Fas ligand rapidly induces
Deletion analysis of the RIP protein has in fact re-cell death by interacting with Fas, which engages FADD
vealed that distinct TNFR1 signals are transduced by the(Fas-associated death domain)/FLICE (FADD-like ICE)
kinase, intermediate, and death domains. Since TNF-
proteins (Chinnaiyan et al., 1995; Muzio et al., 1996).
induced NF-kB activation requires serine phosphoryla-
TNFR1 activation results in stimulation of the cell death
tion of the NF-kB inhibitor protein (IkB) (Beg and Bald-
pathway (Tartaglia et al., 1993) or induction of a protec-
win, 1993), it is possible that RIP may activate the IkB
tive pathway mediated by activation of the nuclear tran- kinase pathway. Yet, RIP mutants that only contain a
scription factor kB (NF-kB), or both (Hsu et al., 1995). kinase domain fail to activate NF-kB, but retain an ability
Originally identified in a yeast two-hybrid screen for to bind TRAF2 (Hsu et al., 1996b). Similarly, a kinase-
Fas-interacting proteins, RIP is a serine/threonine ki- defective RIP restores the TNF-induced NF-kB signal
nase that contains a death domain (Stanger et al., 1995; in a RIP-deficient clone (Ting et al., 1996). However,
Hsu et al., 1996b). In mammalian cells, RIP interacts expression of the RIP intermediate domain results in
weakly with the death receptors Fas and TNFR1 (Hsu both NF-kB activation and TRAF2 interaction. All RIP
et al., 1996b). Ligand-induced trimerization of theTNFR1 mutants containing the C-terminal death domain are
results in the recruitment of the death domain adapter capable of inducing cell death when overexpressed,
protein TRADD (TNFR1-associated death domain pro- demonstrating that the death domain is both necessary
tein) (Hsu et al., 1995). TRADD is also known to interact and sufficient for apoptosis. Thus, the kinase and inter-
with FADD and with the RING finger±containing protein mediate domains of RIP are involved in activation of NF-
TNFR receptor±associated factor 2 (TRAF2) (Hsu et al., kB and TRAF2 binding, whereas the RIP death domain
1996a). RIP interacts via its death domain with TRADD, associates with TRADD and other death domain pro-
and this interaction is TNF dependent (Hsu et al., 1996b). teins to elicit the apoptotic response.
The exact contribution of RIP to the Fas/TNFR1 path-
ways has been difficult to ascertain because of the com-
plexity and apparent functional redundancy in the mam-§To whom correspondence should be addressed (e-mail: kelliher@
rascal.med.harvard.edu). malian cell death pathway. To elucidate the precise
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Figure 1. Generation of rip2/2 Mice
(Top) Targeting of the rip gene. A map of the
targeting vector is shown along with the wild-
type and mutant loci. Restriction enzyme
sites: As, Asp718 ; H, HindIII; E, EcoRI; and
C, ClaI. Homologous recombination of wild
type DNA with pPNT-RIP results in the inser-
tion of pgk-neo gene in exon 2 of the rip gene.
(Bottom) Southern blot analysis of DNA prep-
arations from tails of 18 day embryos from
heterozygote matings. The three genotypic
categories are indicated as wild type (1/1),
heterozygote (1/-), and homozygote (2/2).
Digestion of genomic DNA with Asp718 fol-
lowed by hybridization with the probe de-
picted above the wild-type locus generates
a 21 kb fragment for the wild-type locus and
a 17 kb fragment for the targeted locus.
functional role of RIP in mediating these signal transduc- than their littermates, weighing one-third to one-half
their normal weight. These pups, although feeding,tion pathways in vivo, we have generated RIP-deficient
mice. Mice lacking the RIP death domain kinase appear failed to gain weight and died. No rip2/2 pups survived
beyond 3 days after birth. At autopsy, edema of thenormal at birth, but become runted and die postnatally.
Hence, this study reveals a novel developmental role neck and axillary and inguinal areas was observed in
all of the rip2/2 animals. Examination of rip2/2 animalsfor RIP beyond that of TNF signaling. In addition to the
postnatal lethality, RIP-deficient mice exhibit extensive revealed that all internal organs appeared grossly normal.
apoptosis in the lymphoid and adipose tissues, support-
ing the notion that RIP functions in vivo to suppress cell rip2/2 Mice Exhibit Immune and Adipose
Tissue Defectsdeath.
Since RIP has been implicated in Fas ligand± and TNF-
mediated cell death, the lymphoid lineages in RIP-defi-Results and Discussion
cient mice were examined by flow cytometry. To the
extent that B cell development could be analyzed atTargeted Disruption of rip
To disrupt the murine rip gene in embryonic stem (ES) embryonic day 18, rip2/2 mice contained similar numbers
of B2201 cells in bone marrow as control littermatescells by homologous recombination, we designed a tar-
geting construct that would disrupt exon 2 of the rip (Figure 2B). Flow cytometric analysis of thymus from
some embryonic day 18 RIP-deficient mice revealedgene 50 bp after the ATG initiation codon (Figure 1, top).
To detect homologous recombinants by Southern blot, normal CD4 and CD8 thymocyte populations (Figure
2A), indicating that thymocyte maturation can proceedgenomic DNA isolated from transfected ES cells was
digested with Asp 718 and hybridized with a flanking normally in the absence of RIP. Yet in other rip2/2 mice
at embryonic day 18, dramatic decreases in thymocyteprobe (Figure 1, top and bottom). This assay generated
a 21 kb wild-type band and a 17 kb mutant band. ES viability were observed. Thymic sections from these
rip2/2 mice contained numerous cells with pyknotic nu-cells with a disrupted rip allele were injected into blasto-
cysts to generate chimeric animals. Male mice from a clei, where nuclear fragmentation appeared to have
taken place (Figure 3B). Numerous apoptotic bodiesclone that gave greater than 90% chimerism transmitted
the recombinant allele to their progeny. Heterozygous were observed throughout the thymus in both the cortex
and the medulla. The excessive thymic cell death wasanimals were indistinguishable from wild-type animals
and subsequently were interbred. observed in all rip2/2 mice examined, evident in some
rip2/2 mice at embryonic day 18 and in others at birth.
In addition to the thymic effects, RIP-deficient miceEarly Postnatal Lethality in rip2/2 Mice
No gross phenotypic abnormalities were observed in also displayed abnormal lymph node development. In
contrast to littermate controls, all of the developing rip2/2the heterozygous rip mice but, of a total of 50 genotyped
pups, no homozygotes were obtained, suggesting that lymph nodes lacked normal architecture, appearing ne-
crotic, edematous, and infiltrated with granulocytes (Fig-RIP is essential for survival. Timed matings were subse-
quently used to obtain embryos at different stages of ures 3C and 3D). Granulocytic infiltration and tissue
damage was also observed in the subcutaneous tissue,development. Up to late gestation, wild-type, hetero-
zygous, and homozygous animals were present in the specifically in the dermis and thermogenic fat (data not
shown and Figures 3E and 3F).expected Mendelian ratios. Two to 3 days after birth,
approximately one quarter of thepups appeared smaller Consistent with the tissue inflammation, rip2/2 mice
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those of control littermates. However, differential blood
analysis of rip2/2 mice revealed an increased percentage
of myeloid cells (70% in rip2/2 vs. 20%±25% in rip1/1)
and a concomitant decreasein peripheral blood lympho-
cytes. The increased percentage of myeloid cells in the
peripheral blood most likely reflects the granulocytic
infiltration of lymphoid and subcutaneous tissues.
In the absence of RIP, mice exhibit postnatal lethality
and extensive cell death in the lymphoid and adipose
lineages, revealing that the primary function of RIP in
these tissues is to provide a survival signal. Furthermore,
the postnatal lethality and adipose tissue effects reveal
role(s) for the RIP kinase in mediating other, as yet unde-
fined, signaling pathways.
RIP Does Not Mediate Fas-Induced Apoptosis
To explore the role of RIP in Fas-mediated signaling,
heterozygote rip mice were mated, and at embryonic
day 18 the thymus was removed from all embryos. To
determine the percentage of thymocytes susceptible to
Fas killing, half of the thymus was stained with anti-CD4
and anti-CD8 antibodies and analyzed by flow cytome-
try. The remaining thymocytes were stimulated with
Figure 2. Analysis of Hematopoietic Cells in rip2/2 Mice
anti-mouse Fas antibody, and 18 hr later the percentage
Flow cytometric analysis of hematopoietic cells in the thymus and of dead cells was determined by trypan blue staining.
bone marrow from rip1/1 and rip2/2 neonatal littermates. (A) Viable
Although the cell death induction in rip2/2 thymocytescells residing in the lymphoid gate were analyzed. (B) Total white
appeared somewhat less efficient as compared to thatblood cells were analyzed. The percentage of total cells in a particu-
of 1/1 or 1/2 thymocytes, this reflects the decreasedlar region is indicated.
percentage of viable CD41CD81 cells in the rip2/2 mice.
Viable CD41CD81 thymocytes from RIP-deficient mice
exhibited an immature periportal myeloid cell hyperpla- were as susceptible to killing induced by anti-Fas as
sia and an increase in the splenic red pulp (data not wild-type and heterozygote controls (Table 1). Similar
shown). The total red blood cell and white blood cell results were obtained when RIP-deficient embryonic fi-
broblasts (EFs) were tested for their susceptibility tocounts of rip2/2 mice were not significantly different from
Figure 3. rip2/2 Mice Exhibit Immune andAdi-
pose Abnormalities
Sections through embryonic day 18 thymi
from rip1/1 (A) and rip2/2 (B) mice. Numerous
pyknotic nuclei are observed in rip 2/2 thymus
(arrow in [B]). Sections through the devel-
oping cervical lymph nodes from rip1/1 (C)
and rip2/2 (D) neonates.Arrow, region of gran-
ulocytic infiltration. Section through thermo-
genicbrown fat of rip1/1 (E) and rip2/2 (F) mice.
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Table 1. Fas-Mediated Apoptosis in rip 1/1, 1/2, and 2/2 Thymocytes
Genotype % Dead % CD41CD81 % Dead/%CD41CD81
1/1 69.5 6 9.8 91.5 6 3.0 0.76 6 0.09
1/2 73.4 6 10.4 90.0 6 4.0 0.81 6 0.11
2/2 56.3 6 24.3 68.9 6 30.0 0.83 6 0.21
Embryonic day 18 thymus was stimulated with 1 mg/ml anti-mouse Fas antibody (Jo2) in the presence of 100 ng/ml cycloheximide for 18 hr.
Percentage of dead cells was determined by trypan blue staining. Four wild-type (1/1), seven heterozygote (1/2), and seven rip-deficient
(2/2) animals were tested.
anti-Fas killing (data not shown). Therefore, in the ab- 1996; Van Antwerp et al., 1996; Wang et al., 1996). We
reasoned that the TNF sensitivity observed in rip 2/2 cellssence of RIP, Fas-induced apoptosis remains unaf-
fected, demonstrating that RIP is not required for Fas may reflect an inability to activate NF-kB. To determine
whether TNF-induced NF-kB activation occurs in thesignaling.
absence of RIP, nuclear extracts obtained from embry-
onic day 18 fetal liver-derived Abelson-transformedrip2/2 Cells Are Sensitive to TNFa-Induced
Cell Death preB cell lines treated with hTNFa were analyzed by
electrophoretic mobility shift assay using an NF-kB-spe-The rapid recruitment of RIP to the TNFR1 upon ligand
stimulation (Hsu et al., 1996b) prompted us to investi- cific probe. No evidence of NF-kB activation was ob-
served in TNF-treated rip2/2 cells, whereas an increasegate whether rip2/2 cells differed in their response(s) to
TNFa . Since human TNFa (hTNFa) binds exclusively to in NF-kB binding activity was evident in TNF-treated
rip1/1 cells (Figure 5A). As expected, the NF-kB activitymouse TNFR1 and not to TNFR2 (Lewis et al., 1991), we
were able to distinguish between effects mediated by observed in wild-type cells was reactive to antisera spe-
cific for p65 (data not shown). No differences in bindingthe two mouse TNF receptors. A 4 hr treatment of rip2/2
fibroblasts with human TNFa resulted in a dramatic de- activity were observed when the nuclear extracts de-
crease in cell viability (Figure 4). In contrast, no substan- rived from the rip1/1 and rip2/2 cells were tested with an
tial effect on viability of rip1/1 EFs was noticed at any octamer-1±specific probe (Figure 5B). Failure to activate
time after TNFa treatment (Figure 4). Thus, the absence NF-kB was not due to down-regulation of the NF-kB
of RIP sensitizes fibroblasts to TNFa-induced cell death,
suggesting that the normal function of RIP in the TNFR1
pathway may be to mediate a survival signal.
rip2/2 Cells Fail to Activate NF-kB
in Response to TNFa
Several recent studies have demonstrated that activa-
tion of the transcription factor NF-kB prevents TNF-
induced cell death (Beg and Baltimore, 1996; Liu et al.,
Figure 5. Gel Shift Analysis of rip1/1 and rip2/2 Cells Treated with
TNFFigure 4. rip2/2 Fibroblasts Are Susceptible to TNFa-Induced Cell
Death PreB cell lines were left untreated (2) orstimulated with mouseTNFa
(10ng/ml) or hTNFa (10 ng/ml). Nuclear extracts were prepared andrip1/1 and rip2/2 tail fibroblasts were treated with hTNFa (10 ng/ml)
for 4, 12, and24 hr. Viable cells remaining after treatment with hTNFa analyzed for NF-kB activation by gel shift with 32P end±labeled NF-
kB probe (A) or a control Oct-1 probe (B). Activation of NF-kB byare shown as a percentage of viable untreated cells. Standard error
of the mean was calculated from four independent readings within DOC (C). Cytoplasmic extracts from rip1/1 and rip2/2 cells were left
untreated or reacted with DOC and then analyzed by NF-kB gela single experiment. Identical results were obtained with multiple
independent isolates of embryonic tail fibroblasts. shift.
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abnormalities. Histologic analysis did reveal necrosis of
the thermogenic fat, suggesting potential defect(s) in
adipocyte function. The thymic cell death is first appar-
ent in the rip2/2 embryos at embryonic day 18 and corre-
lates with the emergence of the CD41CD81 cells in the
fetal thymus. Yet postnatal lethality and thymic cell
death arenot features observed inTNFR1-deficient mice
(Pfeffer et al., 1993; Rothe et al., 1993). Therefore, RIP
may be acting in concert with other TNFR family mem-
bers, possibly DR3 in the thymus (Marsters et al., 1996).
Alternatively, the thymic phenotype observed in RIP-
deficient mice may be an indirect effect of the mutation
and, for example, the result of corticosteroid release,
Figure 6. Normal Cytokine-Induced SAPK/JNK Activation in rip2/2 as reported in TRAF3-deficient mice (Xu et al., 1996). It
Cells seems unlikely that the RIP thymic cell death results
rip1/1 and rip2/2 fibroblasts were incubated with TNF (A) or IL-1 (B) from concentrated steroid levels since the phenotype
for the various times indicated or with sorbitol (S) for 15 min. Protein is first evident in utero, when small molecules such as
lysates from individual samples were immunoprecipitated with a
steroids readily diffuse across the placenta.SAPK/JNK-specific antibody, and kinase activity was measured us-
Defects in lymph node development are not observeding a GST-ATF-2 fusion protein as the substrate, as described in
in TNFR1- or TNFR2-deficient mice (Pfeffer et al., 1993;Experimental Procedures.
Rothe et al., 1993; Erickson et al., 1994) but are apparent
in RIP-deficient mice, lymphotoxina (LTa)±deficient
heterodimer in rip2/2 cells. Treatment of cytoplasmic ex- mice (DeTogni et al., 1994), and LTb-deficient mice (Koni
tracts with the detergent DOC, which activates NF-kB, et al., 1996). LTa-deficient mice lack all lymph nodes,
revealed that rip1/1 and rip2/2 cells expressed compara- whereas LTb-deficient mice have normal cervical and
ble amounts of NF-kB (Figure 5C). Similar results were mesenteric lymph nodes. RIP-deficient mice, like LTa-
obtained with nuclear extracts derived from human deficient mice, fail to develop any normal lymph node
TNFa-treated rip2/2 EFs (data not shown). structures. Taken together, these studies suggest that
NF-kB can be activated by a variety of other agents, RIP might mediate growth signals from additional TNFR
including the cytokine interleukin-1 (IL-1) and the bacte- members, possibly the LTb-receptor, known to bind a
rial mitogen lipopolysaccharide (Baeuerle and Henkel, cell surface LTa±LTb heteromer (Crowe et al., 1994), or
1994). However, a dominant-negative RIP has been the putative LTa3-receptor.
shown to inhibit specifically TNF-induced, not IL-1± The phenotype of the RIP-deficient mouse is remark-
induced, NF-kB activation (Hsu et al., 1996b). Consistent ably similar to TRAF2- deficient mouse (Yeh et al., 1997).
with these studies, no differences in NF-kB activity were Both mutant mice exhibit neonatal lethality character-
observed when rip1/1 and rip2/2 cells were treated with ized by a wasting syndrome, lymphopenia, and thymic
IL-1a or lipopolysaccharide, indicating that RIP is a spe- cell death, suggesting that RIP and TRAF2 have similar
cific mediator of the TNF-induced NF-kB pathway (data developmental roles. Yet in the absence of TRAF2, TNF-
not shown). induced NF-kB activation appears for the most part nor-
mal, and sensitivity to TNF-induced cell death is accom-
rip2/2 Cells Exhibit Normal Cytokine-Induced panied by an inability to stimulate SAPK/JNK activity
SAPK/JNK Activation (Yeh et al., 1997). In contrast, in the absence of RIP,
In addition to TNF-induced NF-kB activation, RIP has TNFR1 activation fails to result in NF-kB activation, and
also been implicated in the SAPK/JNK response to TNFa consequently rip2/2 cells undergo TNFa-induced cell
(Liu et al., 1996). To test whether the cytokine-induced death. Together, these studies firmly establish that
SAPK/JNK response was affected by mutation of rip, TRAF2 mediates TNF-inducedSAPK/JNK activation and
rip1/1 and rip2/2 cells were treated with human TNFa or that the primary function of RIP in the TNFR1 pathway
mouse IL-1a for varying periods of time and JNK activity is to transduce the NF-kB signal.
measured by an immune complex kinase assay. In con- Activation of NF-kB requires the site-specific serine
trast to studies in which a dominant-negative RIP inhib- phosphorylation of the NF-kB inhibitor protein, IkB (Ver-
its TNF-induced JNK activation (Liu et al., 1996), no ma et al., 1995; Baldwin, 1996). Recently, several groups
differences in JNK activation were observed when wild- have identified IkB kinases, designated IKK-a and IKK-b,
type and rip2/2 cells were treated with TNFa or IL-1 which mediate the Ser32/Ser36 phosphorylation of IkBa
(Figures 6A and 6B). Taken together, these results sug- and Ser19/Ser23 phosphorylation of IkBb (DiDonato et
gest that protection from TNF-induced cell death medi- al., 1997; Mercurio et al., 1997; Regnier et al., 1997;
ated by RIP involves NF-kB and not SAPK/JNK acti- Woronicz et al., 1997; Zandi et al., 1997). TNFR1 activa-
vation. tion may stimulate RIP kinase activity, which then phos-
In the absence of the RIP death domain±containing phorylates the NF-kB-inducing kinase, NIK (Malinin et
protein, mice exhibit postnatal lethality and immune and al., 1997). Activated NIK in turn phosphorylates IKK-a
adipose lineage defects. Although ostensibly normal at and IKK-b, resulting in IkBa phosphorylation and subse-
birth, RIP-deficient animals fail to gain weight, and die. quent degradation. Yet, a kinase defective RIP restores
Gross and histologic examination of organs that must NF-kB inducibility in a RIP-deficient, mutagenized Jur-
function postnatally (kidneys, liver, lung, and gastroin- kat clone (Ting et al., 1996). Similarly, deletion studies
map the region required for NF-kB activation to thetestinal and neuromuscular systems) reveals no obvious
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Kinase Assaya-helical, intermediate domain of the RIP protein (Hsu
Fibroblasts (5 3 106)were left untreated or treated with hTNFa (15et al., 1996b; Ting et al., 1996), suggesting that the RIP
ng/ml), mouseIL-1a (4 ng/ml) for various periods or 0.4 M sorbitol forkinase is not involved in NF-kB regulation. Both studies,
15 min. Cells were then lysed in an ice-cold lysis buffer (potassium
however, involve RIP overexpression, which may cause phosphate/EDTA [pH 7.05], 5 mM EGTA [pH 7.2], 10 mM MgCl2, 50
TRAF aggregation and NF-kB activation. Further study mM b-glycerophosphate [pH 7.2], 0.5% NP-40, 0.1%Brij-35 [Sigma],
1 mM dithiothreitol, 1 mM sodium orthovanadate, 1 mM phenylmeth-of the IkB kinase pathway in the RIP-deficient cellshould
ylsulfonylfluoride, 0.7 mg/ml pepstatin, and 0.5 mg/ml leupeptin).reveal the mechanism of RIP-mediated NF-kB acti-
Cleared lysates were adjusted to equal protein concentrations asvation.
determined by the Bio-Rad protein assay. SAPK/JNK were immuno-
precipitated using a rabbit polyclonal anti-SAPK/JNK reactive
against JNK1 (Santa Cruz Biotech) and harvested on proteinExperimental Procedures
A-Sepharose beads. The immune complex was washed three times
and then the kinase assay performed in 20 ml of kinase buffer (20Generation of rip2/2 Mice
mM HEPES [pH 7.2], 10 mM MgCl2, 0.1 mg/ml bovine serum albumin,Recombinant phage containing genomic DNA of the rip locus were
3 mM b-mercaptoethanol), 10 mCi 32P, and 1.5 mg of glutathioneisolated from a 129 mouse library (Stratagene) by using a mouse
S-transferase (GST)±ATF-2 fusion protein (Gupta et al., 1995) for 15rip cDNA probe (Stanger et al., 1995). Three genomic clones were
min at 308C. The samples were separated on a 12% sodium dodecylsubcloned into pBluescript IIKS(1) (Stratagene) and mapped using
sulfate±polyacrylamide gel and visualized by autoradiography.restriction enzymes. The rip targeting vector was generated with
the pPNT plasmid (Tybulewicz et al., 1991). The upstream genomic
fragment was excised from a genomic clone as a 5.5 kb NotI±ApaI Acknowledgments
fragment (the NotI site comes from the Bluescript polylinker) and
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